Track Bellicum Pharmaceuticals's other current assets ($920K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2023), BLCM shows a other current assets of $920K. That compares with $1.5M in the prior-year period — down 38.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, BLCM's other current assets is now $920K (was $1.5M) — a 38.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bellicum Pharmaceuticals is outperforming or lagging.
Tracking BLCM's other current assets over time shows whether Bellicum Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $920K That compares with $1.5M in the prior-year period — down 38.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this other current assets page, Stockcircle has Bellicum Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $920K) with ownership activity and broader fundamentals.
Bellicum Pharmaceuticals's other current assets is $920K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.